{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:45:36Z","timestamp":1789634736110,"version":"4.0.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ajog.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ajog.2015.03.003","type":"journal-article","created":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T18:42:23Z","timestamp":1425408143000},"page":"161-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Hereditary breast cancer: an update on risk assessment and genetic testing in 2015"],"prefix":"10.1016","volume":"213","author":[{"given":"Ashley R.","family":"Stuckey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela A.","family":"Onstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2015.03.003_bib1","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/sj.bjc.6605606","article-title":"Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1\/BRCA2\/TP53 status","volume":"102","author":"Evans","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2015.03.003_bib2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/gim.2013.181","article-title":"The Angelina effect: immediate reach, grasp, and impact going public","volume":"16","author":"Borzekowski","year":"2014","journal-title":"Genet Med"},{"key":"10.1016\/j.ajog.2015.03.003_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajog.2015.03.003_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ng853","article-title":"Polygenic susceptibility to breast cancer and implications for prevention","volume":"31","author":"Pharoah","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajog.2015.03.003_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10549-011-1459-5","article-title":"Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies","volume":"127","author":"Peng","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ajog.2015.03.003_bib6","unstructured":"Myriad prevalence data. Available at: www.myriad.com. Accessed Oct. 1,\u00a02014."},{"key":"10.1016\/j.ajog.2015.03.003_bib7","unstructured":"CancerGene with BRCAPRO, MMRpro, PancPRO, and MelaPRO. Available at: http:\/\/www4.utsouthwestern.edu\/breasthealth\/cagene\/. Accessed Oct. 1,\u00a02014."},{"key":"10.1016\/j.ajog.2015.03.003_bib8","unstructured":"Breast Cancer Risk Assessment Tool. Available at: www.cancer.gov\/bcrisktool\/. Accessed Oct. 15,\u00a02014."},{"key":"10.1016\/j.ajog.2015.03.003_bib9","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2015.03.003_bib10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5","article-title":"Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction","volume":"73","author":"Claus","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2015.03.003_bib11","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A\u00a0breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.ajog.2015.03.003_bib12","unstructured":"IBIS Breast Cancer Risk Evaluation Tool. Available at: http:\/\/www.ems-trials.org\/riskevaluator\/. Accessed Dec. 3,\u00a02014."},{"key":"10.1016\/j.ajog.2015.03.003_bib13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/jmg.40.11.807","article-title":"Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme","volume":"40","author":"Amir","year":"2003","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.ajog.2015.03.003_bib14","unstructured":"Cancer news. Available at: www.cancer.org. Accessed Oct. 15,\u00a02014."},{"key":"10.1016\/j.ajog.2015.03.003_bib15","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.2270482","article-title":"Linkage of early-onset familial breast cancer to chromosome 17q21","volume":"250","author":"Hall","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.ajog.2015.03.003_bib16","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.8091231","article-title":"Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13","volume":"265","author":"Wooster","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ajog.2015.03.003_bib17","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2015.03.003_bib18","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1200\/JCO.2008.19.9430","article-title":"Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers","volume":"27","author":"Graeser","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2015.03.003_bib19","unstructured":"National Comprehensive Cancer Network. Available at: www.nccn.org. Accessed Oct. 15,\u00a02014."},{"key":"10.1016\/j.ajog.2015.03.003_bib20","unstructured":"National Comprehensive Cancer Network screening. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf. Accessed Oct. 15,\u00a02014."},{"key":"10.1016\/j.ajog.2015.03.003_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2007.09.031","article-title":"Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions","volume":"107","author":"Lancaster","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2015.03.003_bib22","unstructured":"Myriad prevalence data. Available at https:\/\/www.myriad.com\/lib\/brac\/BART-faq.pdf. Accessed Oct. 15,\u00a02014."},{"key":"10.1016\/j.ajog.2015.03.003_bib23","first-page":"2984","article-title":"Inherited p53 gene mutations in breast cancer","volume":"52","author":"Sidransky","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajog.2015.03.003_bib24","first-page":"344","article-title":"Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients","volume":"51","author":"Lustbader","year":"1992","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajog.2015.03.003_bib25","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1086\/374567","article-title":"Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk","volume":"72","author":"Hwang","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajog.2015.03.003_bib26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/jmg.2004.018036","article-title":"Will the real Cowden syndrome please stand up (again)? Expanding the mutational and clinical spectra of the hamartoma tumour syndrome","volume":"41","author":"Pilarski","year":"2004","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.ajog.2015.03.003_bib27","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","article-title":"Lifetime cancer risks in individuals with germline PTEN mutations","volume":"18","author":"Tan","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajog.2015.03.003_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10897-008-9187-7","article-title":"Cowden syndrome: ac critical review of the clinical literature","volume":"18","author":"Pilarski","year":"2009","journal-title":"J\u00a0Genet Couns"},{"key":"10.1016\/j.ajog.2015.03.003_bib29","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1053\/gast.2000.20228","article-title":"Very high risk of cancer in familial Peutz-Jehgers syndrome","volume":"119","author":"Giardiello","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajog.2015.03.003_bib30","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1053\/gast.2001.29611","article-title":"Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families","volume":"121","author":"Pharaoah","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajog.2015.03.003_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","article-title":"Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation","volume":"345","author":"Meijers-Heijboer","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.03.003_bib32","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","article-title":"Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group","volume":"22","author":"Rebbeck","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2015.03.003_bib33","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","volume":"93","author":"Hartmann","year":"2001","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2015.03.003_bib34","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2015.03.003_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1245\/s10434-013-3230-0","article-title":"Total skin-sparing mastectomy in BRCA mutation carriers","volume":"21","author":"Peled","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajog.2015.03.003_bib36","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/cncr.28050","article-title":"Trends in immediate breast reconstruction across insurance groups after enactment of breast cancer legislation","volume":"119","author":"Yang","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2015.03.003_bib37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00006250-200801000-00039","article-title":"Elective and risk-reducing salpingo-oophorectomy. ACOG Practice bulletin no. 89","volume":"111","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.03.003_bib38","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.03.003_bib39","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.03.003_bib40","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2015.03.003_bib41","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.286.18.2251","article-title":"Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial","volume":"286","author":"King","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2015.03.003_bib42","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-158-8-201304160-00005","article-title":"Use of Medications to reduce risk for primary breast cancer: a systematic review for the US Preventive Services Task Force","volume":"158","author":"Nelson","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2015.03.003_bib43","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","article-title":"Exemestane for breast-cancer prevention in postmenopausal women","volume":"364","author":"Goss","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.03.003_bib44","unstructured":"SGO Clinical Practice Statement: Next Generation Cancer Gene Panels Versus Gene by Gene Testing. Available at: https:\/\/www.sgo.org\/clinical-practice\/guidelines\/next-generation-cancer-gene-panels-versus-gene-by-gene-testing\/. Accessed Dec. 15,\u00a02014."},{"key":"10.1016\/j.ajog.2015.03.003_bib45","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1245\/s10434-012-2257-y","article-title":"Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers","volume":"19","author":"Drohan","year":"2012","journal-title":"Ann Surg Oncol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815001970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815001970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T21:10:02Z","timestamp":1715461802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937815001970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0002937815001970"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2015.03.003","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hereditary breast cancer: an update on risk assessment and genetic testing in 2015","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2015.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}